GlassScriptPhysician profile
Kirk D Clifford
NPI 1366478034
$47,419.32
in general payments reported to CMS, 2019-2025
15 companies · $1,289 in 2025
The $1,289 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $1,000 · 2021: $1,159 · 2022: $8,722 · 2023: $27K · 2024: $8,314 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Royalty Or License: $9,287 · Travel and Lodging: $5,243 · Food and Beverage: $1,067 · Gift: $762 · Entertainment: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,575.00 |
| Royalty Or License | $9,286.52 |
| Travel and Lodging | $5,242.51 |
| Food and Beverage | $1,067.08 |
| Gift | $762.04 |
| Entertainment | $268.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Spine, LLC | $43,786.58 | 2019-2024 | Presson |
| Arthrex, INC. | $1,167.65 | 2024-2025 | |
| Alliance Medical | $1,023.91 | 2025 | |
| Gemini Mountain Medical, LLC | $758.14 | 2024 | |
| Spinal Elements, INC. | $169.28 | 2021 | |
| Cerapedics INC. | $160.94 | 2021 | |
| Bioventus LLC | $136.70 | 2019-2021 | |
| Brainlab, INC. | $53.84 | 2023 | Image Guided Surgical Device |
| Stryker Corporation | $43.09 | 2025 | N/A |
| Kuros Biosciences USA, INC | $40.35 | 2024 | Magnetos |
| Organogenesis INC. | $26.90 | 2024 | Nushield |
| Smith+Nephew, INC. | $18.02 | 2023 | Pico 7, Renasys Go V2 Home |
| Sanofi-Aventis U.S. LLC | $17.24 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $16.68 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,219,211.41 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Clifford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.